IO Biotech, Inc. (IOBT:NASDAQ) closed at $0.048 on April 6, 2026, unchanged on the day. The stock trades 98.3% below its 52-week high of $2.79 and 700.0% above its 52-week low of $0.006. IO Biotech, Inc. is part of the Health Care sector.
In 252 trading sessions since October 22, 2025, IOBT closed higher on 44 days (17%). Its best day was April 20, 2026 (+841.18%) and its worst was April 7, 2026 (-82.92%). The stock moved 10% or more in a single session 34 times. It opened at least 5% above the previous day's high 2 times.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer therapies based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.
Find more stocks like IOBT with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.